お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ
株式会社グローバルインフォメーション
表紙:医療用分子診断の世界市場の分析
市場調査レポート
商品コード
919020

医療用分子診断の世界市場の分析

Market Analysis on Molecular Diagnostics in Healthcare (pre-order)

出版日: 受注後作成 | 発行: M14 Intelligence Research Pvt. Ltd. | ページ情報: 英文 | 納期: お問合せ

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=110.15円
医療用分子診断の世界市場の分析
出版日: 受注後作成
発行: M14 Intelligence Research Pvt. Ltd.
ページ情報: 英文
納期: お問合せ
  • 全表示
  • 概要
  • 目次
概要

当レポートでは、世界の医療用分子診断市場について分析し、市場の基本構造や昨今の変化、主な市場促進・抑制要因、全体的な市場規模の動向見通し、用途別・技術別・地域別の詳細動向、代表的な技術の普及・活用状況、昨今の技術開発/資本取引の動き、今後の市場機会の見通し、といった情報を取りまとめてお届けいたします。

第1章 エグゼクティブサマリー

第2章 分析範囲・手法

第3章 分子診断:業界動向の変化

  • 精密医療業界での分子診断の普及率上昇
  • 技術進歩に伴う、新興国での分子診断の需要増加

第4章 医療用分子診断市場:昨今の有機的・無機的発展の動き

  • 無機的発展:企業合併・買収 (M&A)、投資、融資、事業協力

第5章 FDA (米国食品医薬品局) の法令・規制:分子診断市場の抑制要因

第6章 分子診断の活用分野:感染症、腫瘍、遺伝子検査、血液検査

第7章 分子診断技術の分析

  • PCR (ポリメラーゼ連鎖反応) 技術:迅速・安価なDNA増幅手段
  • FISH (蛍光 in situ ハイブリダイゼーション):染色体内部の特定のDNAシーケンスを探知するための手法
  • シーケンシング (DNA/NGS):ゲノミクス・プロテオミクス・トランスクリプトミクス・メタボロミクス向け利用
  • マイクロアレイ技術:疾患関連の遺伝子/病原体の判定 (ジェノタイピング)
  • INAAT (核酸等温増幅技術):臨床向けの巨大需要
  • その他:電気泳動、質量分析、フローサイトメトリー

第8章 競争力の評価:分子診断市場の競争環境

  • 大手企業の製品・サービス:市場シェアの分析
  • 各地域市場のシェア構造
  • 各企業の最新技術:分子診断市場
  • 昨今の資本取引動向:事業提携・協力、企業合併・買収 (M&A)、融資など
  • 主な分析対象企業:Roche Diagnostics、Qiagen、Becton Dickinson (BD)、Abbott Laboratories、Hologic (Gen-Probeを含む)、Agilent Technologies、Cepheid、Siemens Healthcare、BioMerieux、Quest Diagnostics Incorporated

第9章 付録

目次

M14 Intelligence expertise in precision medicine industry is a leverage of its multiple years of data-evaluation of emerging healthcare technologies. Our team of 2 consultants and 1 subject matter expert of molecular diagnostic technology has been tracking and evaluation the changing dynamics of the industry.

  • The report gives detailed analysis on the changing dynamics, emerging trends, and market opportunities of molecular diagnostics market.
  • The report covers analysis on historical market trend, and market forecast of molecular diagnostics market.
  • The report analyzes the expected future demand of molecular diagnostics and factors that are defining this expected demand.
  • A deep investigation into Molecular diagnostics industry and detailed analysis on its
  • Applications such as Infectious diseases, Oncology, Genetic Testing, Blood Screening
  • Microbiology and Neurological Diseases.
  • Technology such as- Polymerase Chain Reaction (PCR), Hybridization, Sequencing
  • (DNA & NGS), Microarray, Isothermal Nucleic Acid Amplification Technology (INAAT)

Electrophoresis, Mass spectroscopy, Flow Cytometry. Demand for Molecular diagnostics is analysed across different end users such as hospitals, laboratories, pharmaceuticals and biotechnology industries, clinical diagnostics, centres, universities and research organisations which is mentioned in this report.

Molecular Technologies that are analysed are Polymerase Chain Reactions (PCR), Hybridization, Sequencing (DNA & NGS), Microarray, Isothermal Nucleic Acid Amplification Technology (INAAT), Electrophoresis, Mass Spectroscopy, Flow Cytometry.

Leading companies and new entrants in the market are analysed for their revenue, product and service offerings.

The detailed survey on inorganic developments such as partnerships, mergers & acquisition, collaboration and organic developments are mentioned in this report.

Companies offering Molecular Diagnostics Technology mentioned in the report are: Roche Diagnostics, Qiagen, Becton Dickinson (BD), Abbott Laboratories, Hologic, Agilent Technologies, Cepheid, Siemens Healthcare, BioMerieux, Quest Diagnostics Incorporated, Johnson and Johnson, GenMark diagnostics, Alere Inc., Analytik Jena, Danaher Corporation, Illumina, Inc., Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Biocartis Group NV, HiberGene Diagnostics, Celtic Molecular Diagnostics (Pty) Ltd., Laboratory Corporation of America Holdings, DNA Diagnostics Center, Elitechgroup, GE Healthcare, Inc., Genomic Health, Inc., Agendia NV, Luminex Corporation, Oxford Gene Technology, Savyon Diagnostics, Seegene Inc, Transgenomic Inc., Kaneka Eurogentec S.A, Milliporesigma, Myriad Genetics, Inc, Origene Technologies, Inc., Ortho Clinical Diagnostics, Perkinelmer Inc., Promega Corporation, Sorenson Genomics, LLC, Sysmex Inostics GmbH, Wuxi Nextcode, Grifols, Diasorin, 10X Genomics, Bristol-Myers Squibb, Foundation Medicine, HTG Molecular Diagnostics, Merck KGaA, Beckman Coulter Inc., GNA Biosolutions, Asuragen, Inc, AutoGenomics, MolecularMD. The list includes the leading players, new entrants and start-ups.

Table of Contents

Chapter 1: Executive Summary

Chapter 2: Scope and Research Methodology

Chapter 3: Molecular Diagnostics - Changing-Industry Dynamics

  • 3.1. Increasing market penetration of molecular diagnostics in precision medicine industry
  • 3.2. Increasing demand for molecular diagnostics in emerging markets due to advancement in molecular techniques and diagnostics test

Chapter 4: Latest Organic and Inorganic Developments in Molecular Diagnostics in Healthcare

  • Inorganic Developments mentioned in this report are: Acquisitions, Mergers, Investments, Funding and Collaboration

Chapter 5: FDA Rules and Regulations Restraining Factors in Molecular Diagnostics

Chapter 6: Molecular Diagnostics for Applications: Infectious Disease, Oncology, Genetic Testing, Blood Screening

Chapter 7: Molecular Diagnostics Technology Analysis

  • 7.1. Fast and inexpensive polymerase chain reaction (PCR) technology used to amplify small segments of DNA
  • 7.2. Fluorescence in situ hybridization (FISH) a laboratory technique for detecting and locating a specific DNA sequence on a chromosome
  • 7.3. Sequencing (DNA & NGS) including genomics, proteomics, transcriptomics, metabolomics
  • 7.4. Microarray technology used for genotyping and determination of disease-relevant genes or agents causing diseases
  • 7.5. Isothermal Nucleic Acid Amplification Technology (INAAT) high on demand especially for Clinical application
  • 7.6. Other technologies includes: Electrophoresis, Mass spectroscopy and Flow cytometry

Chapter 8: Competition Assessment: Competitive Landscape in Molecular Diagnostics-

  • 8.1. Molecular Diagnostics Market share analysis by Products & Services offered by the Leading Companies
  • 8.2. Region wise market share analysis of Molecular Diagnostics Market
  • 8.3. Latest Technologies offered by the competitors in Molecular Diagnostics Market
  • 8.4. Latest Developments such as partnerships, collaboration, mergers & acquisitions, funding by the competitors in molecular Diagnostics market
  • 8.5. Leading Players in Molecular Diagnostics Market mentioned in report: Roche Diagnostics, Qiagen, Becton Dickinson (BD), Abbott Laboratories, Hologic (includes Gen-Probe), Agilent Technologies, Cepheid, Siemens Healthcare, BioMerieux, Quest Diagnostics Incorporated

Chapter 9: Appendix

  • 9.1. References
  • 9.2. Excerpt of interviews with leading industry players
株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.